PT Palma Serasih Tbk (IDX:PSGO)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,883,100	3,562,650	2,507,050	2,752,100	4,071,600	2,243,150
Market Cap Growth	16.78%	42.10%	-8.90%	-32.41%	81.51%	-40.50%
Enterprise Value	3,881,025	3,550,996	3,722,237	4,304,005	5,843,224	3,998,709
Last Close Price	206.00	180.83	120.55	132.33	195.78	107.86
PE Ratio	9.30	10.16	4.57	10.68	19.04	84.64
PS Ratio	1.58	1.67	1.22	1.40	2.31	2.41
PB Ratio	1.55	1.46	1.12	1.63	2.86	1.85
P/TBV Ratio	1.55	1.46	1.12	1.63	2.86	1.88
P/FCF Ratio	9.95	15.78	5.02	7.20	16.79	-
P/OCF Ratio	7.11	9.32	3.73	5.15	11.03	8.03
EV/Sales Ratio	1.58	1.67	1.82	2.18	3.31	4.30
EV/EBITDA Ratio	5.55	5.44	6.60	7.04	11.96	14.50
EV/EBIT Ratio	6.77	7.09	9.10	9.27	15.80	22.61
EV/FCF Ratio	9.94	15.73	7.46	11.26	24.10	-
Debt / Equity Ratio	0.45	0.51	0.71	1.29	1.44	1.64
Debt / EBITDA Ratio	1.60	1.88	2.79	3.53	4.17	7.10
Debt / FCF Ratio	2.86	5.46	3.17	5.67	8.46	-
Asset Turnover	0.65	0.52	0.49	0.50	0.50	0.28
Inventory Turnover	10.46	7.26	6.12	6.63	11.11	6.42
Quick Ratio	2.23	2.25	2.37	1.42	1.55	1.18
Current Ratio	2.81	2.79	2.77	2.01	2.28	1.94
Return on Equity (ROE)	17.62%	14.99%	28.00%	16.57%	16.23%	2.22%
Return on Assets (ROA)	9.44%	7.70%	6.14%	7.37%	6.48%	3.32%
Return on Capital (ROIC)	10.14%	8.36%	6.66%	7.92%	6.93%	3.54%
Return on Capital Employed (ROCE)	17.20%	14.90%	11.70%	13.30%	11.20%	5.70%
Earnings Yield	10.75%	9.84%	21.91%	9.36%	5.25%	1.18%
FCF Yield	10.05%	6.34%	19.92%	13.88%	5.95%	-1.34%
Dividend Yield	3.88%	4.42%	6.64%	-	-	-
Payout Ratio	36.11%	43.01%	-	-	-	-
Buyback Yield / Dilution	-0.04%	-	-	-	-	-31.37%
Total Shareholder Return	3.85%	4.42%	6.64%	-	-	-31.37%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.